MétaCan
Menu
Back to cohort
Record W4404582246 · doi:10.1016/j.eclinm.2024.102924

The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000–2021: a systematic analysis for the Global Burden of Disease Study 2021

2024· article· en· W4404582246 on OpenAlexfundno aff
Atalel Fentahun Awedew, Hannah Han, Bétyna N. Berice, Maxwell Dodge, R Schneider, Mohsen Abbasi‐Kangevari, Ziyad Al‐Aly, Omar Almidani, Saba Alvand, Jalal Arabloo, Aleksandr Y. Aravkin, Tegegn Mulatu Ayana, Nikha Bhardwaj, Pankaj Bhardwaj, Sonu Bhaskar, Boris Bikbov, Florentino Luciano Caetano dos Santos, Jaykaran Charan, Natália Martins, Omid Dadras, Xiaochen Dai, Lankamo Ena Digesa, Muhammed Elhadi, Mohamed A. Elmonem, Christopher Imokhuede Esezobor, Ali Fatehizadeh, Teferi Gebru Gebremeskel, Motuma Erena Getachew, Seyyed‐Hadi Ghamari, Simon I Hay, Irena Ilić, Milena Ilić, Umesh Jayarajah, Seyed Behzad Jazayeri, Min Seo Kim, Sang-Woong Lee, Shaun Wen Huey Lee, Stephen S Lim, Mansour Adam Mahmoud, Ahmad Azam Malik, Alexios‐Fotios A. Mentis, Tomislav Mestrovic, Irmina Maria Michałek, Gedefaye Nibret Mihretie, Erkin М Мirrakhimov, Ali H. Mokdad, Mohammad Ali Moni, Maryam Moradi, Christopher J L Murray, Alberto Ortíz, Shrikant Pawar, Norberto Perico, Mohammad‐Mahdi Rashidi, Reza Rawassizadeh, Giuseppe Remuzzi, Austin E Schumacher, Ambrish Singh, Valentin Yurievich Skryabin, Anna Aleksandrovna Skryabina, Ker‐Kan Tan, Musliu Adetola Tolani, Sahel Valadan Tahbaz, Rohollah Valizadeh, Bay Vo, Asrat Arja Wolde, Seyed Hossein Yahyazadeh Jabbari, Fereshteh Yazdanpanah, Arzu Yiğit, Vahit Yiğit, Mazyar Zahir, Zhi‐Jiang Zhang, Alimuddin Zumla, M. Ashworth Dirac

Bibliographic record

VenueEClinicalMedicine · 2024
Typearticle
Languageen
FieldMedicine
TopicKidney Stones and Urolithiasis Treatments
Canadian institutionsnot available
FundersJapan Society for the Promotion of ScienceCanadian Institutes of Health ResearchHorizon 2020 Framework ProgrammeFresenius Medical Care North AmericaFondazione CariploAstellas PharmaBGI GroupMinistry of Education, Culture, Sports, Science and TechnologyAustralian Academy of ScienceMinistarstvo Prosvete, Nauke i Tehnološkog RazvojaCardiff UniversityNational Institute for Health and Care ResearchNational Cerebral and Cardiovascular CenterSanofiGovernment of CanadaHellenic Foundation for Research and InnovationEuropean CommissionDepartment of Neurology, College of Medicine, Medical University of South CarolinaAmicus TherapeuticsSociedad Madrileña de NefrologíaInternational Society of NephrologyAlexion PharmaceuticalsAstraZenecaIdorsia PharmaceuticalsBill and Melinda Gates FoundationAmgenEuropean Regional Development FundPolitecnico di Milano
KeywordsMedicineBurden of diseaseDisease burdenDiseaseEnvironmental healthPathology

Abstract

fetched live from OpenAlex

Background: Urolithiasis is a common urological problem that is associated with high morbidity. A comprehensive assessment of the non-fatal and fatal health trends of urolithiasis by age, sex, and geography over time is necessary to inform policy to control this surgically managed non-communicable disease. Methods: This study was conducted using the standard GBD methodology and analytic tools. Cause-specific mortality rate (CSMR) was estimated using vital registration and verbal autopsy data and the Cause of Death Ensemble model (CODEm) modelling tool. CSMR estimates and incidence data from medical insurance claims and hospital discharges were analysed using a Bayesian meta-regression modelling tool, DisMod-MR 2.1, to estimate age-, sex-, and location-specific incidence of urolithiasis between 2000 and 2021. Disability-adjusted life-years (DALYs) were the sum of years of life lost (YLL) and years lived with disability (YLDs). YLLs due to urolithiasis were calculated by multiplying the estimated number of deaths by the standard life expectancy at the age of death. YLDs were estimated by multiplying the disability weight by the symptomatic proportion of urolithiasis cases. The Global Burden of Diseases study used de-identified data, approved by the University of Washington IRB (Study Number 9060). Findings: There were 106 million (95% UI 88.3-129.0) incident cases of urolithiasis in 2021, of which 67% were in men (71.1 million [59.4-86.2)]). The global number of incident cases, deaths, and DALYs increased by 26.7% (23.8-29.8), 60.3% (41.5-84.7), and 34.5% (24.6-47.3), respectively, between 2000 and 2021. The global age-standardised incidence rate of urolithiasis experienced a significant decrease of 17.5% (14.7-20.0), while the age-standardised DALYs rate saw a reduction of 15.1% (6.8-21.3). Twelve GBD regions showed declining trends in the age-standardised incidence rate of urolithiasis between 2000 and 2021, and the remaining nine GBD regions had an increasing trend of age-standardised rates of urolithiasis. A significant increase in the age-standardised incidence rate of urolithiasis was observed in Central America, Tropical Latin America, and the Caribbean regions, whereas notable decline was observed in east Asia, eastern Europe, central Europe, and high-income North America. It was observed that the global age-standardised death rate was less than 0.5 per 100,000 across all GBD regions and less than 1 per 100,000 across all SDI quintiles, with fairly stable global age-standardised death rates of urolithiasis between 2000 and 2021. The age-standardised incidence rate of urolithiasis was 837 (688-1034) in low SDI regions and 1443 (12,108-1734) in high-middle SDI regions. Furthermore, the age-standardised DALY rate showed a decreasing trend across all SDI quintiles over the same period: high-middle SDI (-28.9% [-34.4 to -23.0]), middle SDI (-22.6% [-30.5 to -10.9]), and low-middle SDI (-2.9% [-15.8 to 12.9]). Interpretation: Global urolithiasis incidence and DALY rates have decreased, while the death rate has stabilised worldwide, showing significant variability among regions, SDI levels, and countries. This could be due to effective preventive measures c on urolithiasis risk factors, effective public health education, lifestyle changes, and early interventions and improved health care access at the global level. This analysis offers relevant insights into global, regional, and country-specific urolithiasis trends. Funding: Bill & Melinda Gates Foundation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.018
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.037
Threshold uncertainty score0.073

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.018
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0050.022
Bibliometrics0.0080.012
Science and technology studies0.0000.001
Scholarly communication0.0020.001
Open science0.0010.002
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.364
Teacher spread0.334 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations76
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueEClinicalMedicineSame topicKidney Stones and Urolithiasis TreatmentsFrench-language works237,207